Ophthalmic Formulation and Drug Delivery Technical Services

Contact Us

Ophthalmic and Ocular Consulting:
Drug Delivery | Formulations


Alan L. Weiner, Ph.D.


Alan L. Weiner, Ph.D.

Publications


Alan Weiner

Clinical Studies


Gomes, J.A.P, Azar, D.T, Baudouin, C., Efron, N., Hirayama, M., Horwath-Winter, J., Kim, T., Mehta, J.S., Messmer, E.M., Pepose, J.S., Sangwan, V.S., Weiner, A.L., Wilson, S.E., Wolffsohn, J.S. (2017) TFOS DEWS II Report - Iatrogenic Dry Eye, The Ocular Surface 516-543, http://dx.doi.org/10.1016/j.jtos.2017.05.004

Dubiner, H.B, Sircy, M.D, Landry, T., Bergamini, M.V.W., Silver, L.H, Turner, F.D, Robertson, S., Andrew, R.M, Weiner, A.L., and Przydryga,J., (2004) Comparison of the Diurnal Ocular Hypotensive Efficacy of Travoprost and Latanoprost Over a 44 Hour Period in Patients With Elevated Intraocular Pressure, Clinical Therapeutics, 26 (1), 84-91

Netland, P.A., Robertson, S.M., Sullivan, E.K., Silver, L., Bergamini, M.V.W., Krueger, S., Weiner, A.L., Davis, A.A., and the Travoprost Study Groups, (2003) Response to Travoprost in Black and Non-black Patients With Open-Angle Glaucoma or Ocular Hypertension, Adv. Therapy, 20, 149-163

Netland, P.A., Sullivan, E.K., Bergamini, M.V.W., Weiner, A.L., Landry, T.A., Robertson, S.M., (2003) Central Corneal Thickness of Black and Non-Black Patients with Open-Angle Glaucoma or Ocular Hypertension and IOP Response to Travoprost 0.004% Therapy, ARVO Abst. 2196

DuBiner, H., Kim, J., Ratliff, M., Teague, J., Landry, T., Bergamini, M.V.W., Weiner, A.L, (2002) Response of IOP to TRAVATAN® over 24 hours, Am. Soc. Cataract and Refractive Surg., Annual Meeting, Abstract 624

Fellman, R.L., Sullivan, E.K., Ratliff, M., Whitson, J.T., Turner, F.D., Weiner, A.L., Davis, A.A., and the Travoprost Study Group (2002) IOP-Lowering Efficacy and Safety of Travoprost Compared to Timolol as Primary Therapy in Patients with Open-Angle Glaucoma or Ocular Hypertension, Ophthalmol. 109, 998-1008

Netland, P.A., Landry, T., Sullivan, E.K., Andrew, R., Silver, L., Weiner, A., Mallick, S., Dickerson, J., Bergamini, M.V.W., Robertson, S.M., Davis, A.A., and the Travoprost Study Group, (2001) Travoprost Compared With Latanoprost And Timolol In Patients With Open-Angle Glaucoma Or Ocular Hypertension, Amer. J. Ophthalmol, 132: 472-484

Orengo-Nania, S., Landry, T., Von Tress, M., Silver, L.H., Weiner, A.L., Davis, A.A., and the Travoprost Study Group (2001) Travoprost Is Effective Adjunctive Therapy In Patients With Uncontrolled IOP While Using Timolol 0.5%, Amer. J. Ophthalmol. 132(6), 860-868

Robertson, S., Sullivan, E.K., Silver, L.H., Bergamini, M.V.W., Krueger, S., Turner, F.D., Davis, A.A., Weiner, A.L., and the Travoprost Study Groups, (2001) Differences Between Black and Non-Black Patients with Open-Angle Glaucoma or Ocular Hypertension in IOP-Lowering Response to Travoprost, Invest. Ophthalmolol. Vis. Sci, 42 (4), S559

Netland, P.A., Landry T., Silver, L.H., Sullivan, E.K , Andrew, R., , Weiner, A.L., Bergamini, M.V.W., Robertson, S. , Mallick, S., Davis, A.A., and the Travoprost Study Group, (2001) IOP-Lowering Efficacy And Safety Of Travoprost Compared To Latanoprost And Timolol In Patients With Open Angle Glaucoma Or Ocular Hypertension, Invest. Ophthalmol. Vis. Sci., 42 (4), S556

Whitson, J.T., Ratliff, M., Fellman, R.L., Sullivan, E.K., Turner, F.D., Silver, L.H., Weiner, A.L. and the Travoprost Study Group, (2001), Travoprost, A New Prostaglandin Analogue, Is Superior To Timolol In Lowering IOP In Patients With Open-Angle Glaucoma Or Ocular Hypertension, Invest. Ophthalmol. and Vis. Sci., 42 (4), S557

Orengo-Nania, S.D., Landry, T., Von Tress, M., Silver, L.H., Dickerson, J., Weiner, A.L., Davis, A.A. and the Travoprost Study Group (2001), Travoprost Significantly Decreased IOP In Patients With Open-Angle Glaucoma Or Ocular Hypertension When Used Adjunctively With Timolol, Invest. Ophthamol. Vis. Sci., 42 (4), S820

DuBiner, H., Kothe, A.C., Sharma, V., Mallick, S., Andrew, R., Sullivan, E.K., Weiner, A.L., Desantis, L.M., Krueger, S., Bergamini, M.V.W., and the Study Group (2001) A Comparison of the Diurnal IOP-Lowering Efficacy of Levobetaxolol 0.5% vs. Brimonidine 0.2% in Patients with Open-Angle Glaucoma or Ocular Hypertension, Invest. Ophthalmolol. Vis. Sci, 42 (4), S417


Medical Writer for Publications


Cummings, S. Schmitt-Lieb, A, Rotermund O. (2012) Prospective Crossover Study Comparing Two Daily Disposable Toric Lenses for Comfort, Vision, Fit, and Preference, Contact Lens & Anterior Eye, Submitted. 

Abstract: [Cummings, S. Schmitt-Lieb, A, Rotermund O. (2012) A randomised clinical comparison of two daily disposable toric lenses: nelfilcon A versus etafilcon A, Contact Lens & Anterior Eye, 35 (1), e3]

 

© Copyright 2010 | DrugDel Consulting, LLC | All rights reserved.